GlassScriptPrepare for your visit
Douglas Key
Portland, OR · NPI 1083883334
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$6,448.99
in general payments reported to CMS, 2019-2025 · $460 in 2025
The $460 reported for 2025 was more than what 77% of providers received nationally.
Who reported paying
General payments only, top 4 by amount.
- Abbvie INC. $3,250.43
- Allergan, INC. $2,915.68
- Merz North America, INC. $263.39
- Galderma Laboratories, L.P. $19.49
Drugs and devices associated with these payments
Xeomin Botox
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Douglas Key listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/139561/douglas-key